Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test (NCT04264468) | Zhejiang Cancer Hospital | 2019-05-14 |
Track Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.